Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
11.18
-0.10 (-0.89%)
At close: Feb 13, 2026
SHE:002898 Revenue
Sailong Pharmaceutical Group had revenue of 64.31M CNY in the quarter ending September 30, 2025, with 2.60% growth. This brings the company's revenue in the last twelve months to 244.84M, down -19.46% year-over-year. In the year 2024, Sailong Pharmaceutical Group had annual revenue of 263.57M, down -15.15%.
Revenue (ttm)
244.84M
Revenue Growth
-19.46%
P/S Ratio
8.04
Revenue / Employee
476.35K
Employees
514
Market Cap
1.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 263.57M | -47.06M | -15.15% |
| Dec 31, 2023 | 310.63M | 46.43M | 17.58% |
| Jan 1, 2023 | 264.19M | 17.11M | 6.93% |
| Jan 1, 2022 | 247.08M | 126.39M | 104.73% |
| Dec 31, 2020 | 120.68M | -172.78M | -58.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Sito Bio-technology | 954.76M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Guiyang Xintian Pharmaceutical | 755.34M |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |
| Hubei Goto Biopharm | 626.28M |
| Tiansheng Pharmaceutical Group | 516.17M |
| Jiangsu Sihuan Bioengineering | 341.90M |
| Shanghai Rightongene Biotechnology | 191.78M |